PFE
6:45 AM
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
Trial Results • Phase 3pfizer.com
Catalyst Calendar
Thu, Jul 30, 2026
1 updatesMon, Jun 22, 2026
1 updatesPFE
4:30 PM
Sat, Jun 6, 2026
1 updatesPFE
9:00 AM
Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
Trial Results • Phase 2pfizer.com
Sat, May 30, 2026
1 updatesPFE
8:00 AM
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
Trial Results • Phase 3pfizer.com